Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 5.8B | 14.6B | 12.7B | 12.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.3B | 1.2B | 1.2B | 1.1B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 420M | 411M | 426M | 424M |
Other income expense | 59M | 72M | 88M | 76M |
Pretax income | 2.1B | 2.3B | 1.4B | 1.3B |
Tax provision | 406M | 274M | 252M | 280M |
Net income | 1.7B | 2.1B | 1.1B | 972M |
Basic EPS | — | 1.0 | 0.5 | 0.5 |
Diluted EPS | — | 1 | 0.5 | 0.5 |
Basic average shares | — | 1.8B | 1.8B | 1.8B |
Diluted average shares | — | 1.8B | 1.8B | 1.8B |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.7B | 2.1B | 1.1B | 972M |
Minority interests | -22M | -131M | -39M | -55M |
Preferred stock dividends | 47M | 97M | 51M | 51M |